Changes to policy on drug good manufacturing practices and DEL enforcement (POL-0004)
Health Canada has made changes to the policy on drug good manufacturing practices (GMP) and drug establishment licence (DEL) enforcement (POL-0004). This policy supports the consistent and transparent application of compliance and enforcement actions under Canada’s GMP and DEL regulatory schemes.
Organization:
Health Canada
Resource Formats:
- HTML